[VASOMOTOR EFFECTS OF GANGLIOPLEGIC AGENTS].
D064751:Ammonium Compounds; D001337:Autonomic Agents; D008725:Bis-Trimethylammonium Compounds; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D006801:Humans; D009538:Nicotine; D010600:Pharmacology; D000644:Quaternary Ammonium Compounds; D013757:Tetraethylammonium Compounds; D014666:Vasomotor System
D064751:Ammonium Compounds; D001337:Autonomic Agents; D008725:Bis-Trimethylammonium Compounds; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D000644:Quaternary Ammonium Compounds; D013757:Tetraethylammonium Compounds; C100246:azamethonium compounds; D009538:Nicotine
AMMONIUM COMPOUNDS; AUTONOMIC DRUGS; AZAMETHONIUM COMPOUNDS; GANGLIONIC BLOCKADERS; HEXAMETHONIUM COMPOUNDS; METHONIUM COMPOUNDS; NICOTINE; PHARMACOLOGY; REVIEW; TETRAETHYLAMMONIUM COMPOUNDS; VASOMOTOR SYSTEM
EFFETTI VASOMOTORI DEI GANGLIOPLEGICI.